United Kingdom

People: Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

9:00pm BST
Change (% chg)

$-0.02 (-0.60%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Livnat Savitsky, Kinneret 

Dr. Kinneret Livnat Savitsky has been appointed Director at Compugen Ltd. effective June 11, 2018. Dr. Livnat Savitsky's work experience includes the following roles: Vice President - Biology, Research & Development at the Company (2000-2004), Interim Chief Executive Officer and Board Member of FutuRx Ltd., Director at various companies, Consultant and Chief Executive Officer at BioLineRx Ltd. (2010-2016). Dr. Livnat Savitsky holds a Bachelor of Science degree in Biochemistry from Tel Aviv University, a Bachelor of Science degree in Biology from The Hebrew University of Jerusalem and a Master of Science degree and a Doctorate of Science degree, both in Human Genetics from Tel Aviv University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --